Afatinib (BIBW2992)

Catalog No.S1011

Afatinib (BIBW2992) Chemical Structure

Molecular Weight(MW): 485.94

Afatinib (BIBW2992) inhibits EGFR/ErbB irreversibly in vitro with IC50 of 0.5, 0.4, 10, 14, 1 nM for EGFRwt, EGFR L858R , EGFR L858R/T790M ErbB2 (HER2) and ErbB4 (HER4), respectively.

Size Price Stock Quantity  
In DMSO USD 240 In stock
USD 120 In stock
USD 210 In stock
USD 570 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 37 Publications

4 Customer Reviews

  • Cytoxicity of irreversible EGFR TKIS and ethacrynic acid on breast cells lines. A, Mean IC50 value of Afatinib.

    Oncotarget, 2016, 7(36):58038-58050. Afatinib (BIBW2992) purchased from Selleck.

    Inhibition of signaling pathway activation in lung tumor cell lines by kinase inhibitors. Lung tumor cells were cultured in 10% FBS until reaching ∼80% confluence and then the cells were starved in serum-free medium for overnight, followed by 4-hour treatment with the inhibitors. Cell lysates were then prepared and used for determination of the pathway activation signals by the CEER assay.

    Int J Proteomics 2011 2011, 215496. Afatinib (BIBW2992) purchased from Selleck.

  • Inhibition of anchorage-independent growth of lung tumor cell lines by selected inhibitors. Each selected cell line was treated with the indicated inhibitor at 0.1 μM and 1 μM concentrations for two weeks and cell colony size formation was scored under the Nikon inverted-phase microscope.

    Int J Proteomics 2011 2011, 215496. Afatinib (BIBW2992) purchased from Selleck.

    After starved in serum-free medium for 24h, Breast cancer cells incubated with the indicated concentrations of BIBW2992 for 3h,followed by 15-minute stimolation of 100ng/ml EGF

    Dr. Zhang of Tianjin Medical University. Afatinib (BIBW2992) purchased from Selleck.

Purity & Quality Control

Choose Selective EGFR Inhibitors

Biological Activity

Description Afatinib (BIBW2992) inhibits EGFR/ErbB irreversibly in vitro with IC50 of 0.5, 0.4, 10, 14, 1 nM for EGFRwt, EGFR L858R , EGFR L858R/T790M ErbB2 (HER2) and ErbB4 (HER4), respectively.
Targets
EGFR (L858R) [1]
(Cell-free assay)
EGFR (wt) [1]
(Cell-free assay)
ErbB4 [2]
(Cell-free assay)
EGFR (L858R/T790M) [1]
(Cell-free assay)
HER2 [1]
(Cell-free assay)
0.4 nM 0.5 nM 1 nM 10 nM 14 nM
In vitro

BIBW2992 shows potent activity against both wild-type and mutant forms of EGFR and HER2. It is similar to Gefitinib in potency against L858R EGFR, but about 100-fold more active against the Gefitinib resistant L858R-T790M EGFR double mutant. BIBW2992 exhibits potent effects on both EGFR and HER2 phosphorylation in vivo. It compares favorably to reference compounds (such as Lapatinib et al.) in all cell types tested, such as human epidermoid carcinoma cell line A431 expressing wt EGFR, murine NIH-3T3 cells transfected with wt HER2, as well as breast cancer cell line BT-474 and gastric cancer cell line NCI-N87, which express endogenous HER2. [1]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HDLM-2 MkXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2jjcGlEPTB;MD6wNFU4OiEQvF2= NHPnfGpUSU6JRWK=
KASUMI-1 M1vQcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NG\GSJVKSzVyPUCuNFA6OTFizszN NUO3NZRrW0GQR1XS
HCC2218 NVrZeHk5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVjJR|UxRTBwMEC5PFch|ryP NGrNdJhUSU6JRWK=
KARPAS-45 NGrnRYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1XoSWlEPTB;MD6wNVY4OSEQvF2= MXnTRW5ITVJ?
HSC-4 MofJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEfaV5NKSzVyPUCuNFE4PDhizszN MYHTRW5ITVJ?
CHL-1 M1P1N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUnsbnJWUUN3ME2wMlAyQDN7IN88US=> NEP3XHpUSU6JRWK=
KY821 M4Xvcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MojhTWM2OD1yLkCyNFYh|ryP NF;GfoFUSU6JRWK=
NCI-N87 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{P3N2lEPTB;MD6wNlc4OyEQvF2= M3GzWHNCVkeHUh?=
DOK M4XqZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlfTTWM2OD1yLkCzNVk1KM7:TR?= M1fNRXNCVkeHUh?=
DSH1 MkXkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MULJR|UxRTBwMEOzNVQh|ryP MX3TRW5ITVJ?
MDA-MB-175-VII M33K[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYPGV4oxUUN3ME2wMlA{PDF4IN88US=> Ml\pV2FPT0WU
NCI-H2170 NV65[WJTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NULSNm84UUN3ME2wMlA{PzJ6IN88US=> MY\TRW5ITVJ?
BT-474 M{XWN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MorZTWM2OD1yLkC0PVg3KM7:TR?= NWjiV2tDW0GQR1XS
EFO-27 NFLic4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYjNcpFpUUN3ME2wMlA2OTh{IN88US=> MmHzV2FPT0WU
NCI-H720 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX7WbJR2UUN3ME2wMlA2OzJ3IN88US=> MlviV2FPT0WU
PC-14 M4ewZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlL0TWM2OD1yLkC1OlY5KM7:TR?= NI\xZ|JUSU6JRWK=
EC-GI-10 MkTpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2q1SWlEPTB;MD6wOVkyOiEQvF2= NXTFc5g1W0GQR1XS
KYSE-450 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3nMc2lEPTB;MD6wOVk4QCEQvF2= NYPsOlM5W0GQR1XS
BPH-1 MlW5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoLUTWM2OD1yLkC1PVg5KM7:TR?= M{TwUXNCVkeHUh?=
NCI-H292 MonLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MorqTWM2OD1yLkC2NFkh|ryP M2XRT3NCVkeHUh?=
H9 M{\lW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1nj[2lEPTB;MD6wO|E{OiEQvF2= NGe5e|lUSU6JRWK=
NCI-H526 M1zBWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlfyTWM2OD1yLkC3PFI{KM7:TR?= M4HxVnNCVkeHUh?=
NCI-H1623 NEf1ToNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkWyTWM2OD1yLkC4NFI2KM7:TR?= MUTTRW5ITVJ?
KYSE-140 NYD3WY5vT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVvJR|UxRTBwMEizN{DPxE1? NHvUV|hUSU6JRWK=
Ca9-22 NXGwOmpnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWnhVFhLUUN3ME2wMlA5OzV|IN88US=> M4jYOHNCVkeHUh?=
AU565 NYLOWYQ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlPxTWM2OD1yLkC4OVA1KM7:TR?= NHfvXpNUSU6JRWK=
ZR-75-30 MoLFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWrJR|UxRTBwMEm1OFUh|ryP M2ToOXNCVkeHUh?=
NCI-H1770 M3PId2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlLiTWM2OD1yLkGwNlgh|ryP M4CxenNCVkeHUh?=
LB2241-RCC M37ZPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2XoR2lEPTB;MD6xNFg5PCEQvF2= MXPTRW5ITVJ?
CAL-39 MnXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUTwe|ZKUUN3ME2wMlEyPzl{IN88US=> NVrhN2F1W0GQR1XS
UACC-893 M{DnRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYqycY5sUUN3ME2wMlEyQDh3IN88US=> MWfTRW5ITVJ?
LU-65 NWrVZXliT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVrJR|UxRTBwMUK2N|Mh|ryP NEHmeYpUSU6JRWK=
HN NF;3enlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn:1TWM2OD1yLkGzNFc4KM7:TR?= NFi4O21USU6JRWK=
TI-73 MljxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIj3UZFKSzVyPUCuNVQ4OTVizszN NFnudYZUSU6JRWK=
KU812 MoW0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mmr5TWM2OD1yLkG1OFU3KM7:TR?= MWLTRW5ITVJ?
SW13 NF3GTGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHvSbm9KSzVyPUCuNVYzOTZizszN NYTtbXRuW0GQR1XS
BB30-HNC MlXYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3T5TmlEPTB;MD6xOlU4PiEQvF2= NIfZe2JUSU6JRWK=
HSC-2 NVPBWIlTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX3JR|UxRTBwMU[4N|ch|ryP Mne4V2FPT0WU
BV-173 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mme1TWM2OD1yLkG3OVk3KM7:TR?= NV7w[5E2W0GQR1XS
CAL-27 M1XJXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXXJR|UxRTBwMUe2N|Yh|ryP MXXTRW5ITVJ?
SBC-1 NEX4U4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGTXRWZKSzVyPUCuNVg6PTlizszN NH7wUYNUSU6JRWK=
CAL-33 NX3kWGdlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3PicGlEPTB;MD6yNFE5PCEQvF2= M333SnNCVkeHUh?=
NCI-H209 Mn3DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2nocmlEPTB;MD6yNFQ3KM7:TR?= NEfiN5BUSU6JRWK=
COR-L105 NHHr[41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4T6b2lEPTB;MD6yNVA5PCEQvF2= NEf0WWJUSU6JRWK=
HSC-3 Ml61S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NG\WW5dKSzVyPUCuNlEyQThizszN MmPoV2FPT0WU
NCI-H69 M3O4Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{C3OmlEPTB;MD6yNVQ2OSEQvF2= NIC5UFlUSU6JRWK=
MOLT-13 Mkf6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGDZboVKSzVyPUCuNlM6PzVizszN MnfGV2FPT0WU
ML-2 M1zCSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2DJfmlEPTB;MD6yOFgxOiEQvF2= NF7lWWlUSU6JRWK=
IGROV-1 MnjZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2KxZWlEPTB;MD6yOVk2OiEQvF2= NGDUZ3ZUSU6JRWK=
TK10 MlfVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV7odo04UUN3ME2wMlI3PzN6IN88US=> M3\5VXNCVkeHUh?=
EoL-1-cell NVvpSVFmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2fydGlEPTB;MD6yOlg6OiEQvF2= M{jQWHNCVkeHUh?=
HO-1-N-1 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUTJR|UxRTBwMke4OVMh|ryP MVLTRW5ITVJ?
BHY MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEnFNnRKSzVyPUCuNlg3PTVizszN MYTTRW5ITVJ?
LU-139 NUWweWo{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX3Od41FUUN3ME2wMlMxPTFizszN M{fhTnNCVkeHUh?=
23132-87 NXHa[pdbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4TrSWlEPTB;MD6zNVkzOyEQvF2= M{S5enNCVkeHUh?=
ACHN NFLZclRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M37vS2lEPTB;MD6zNVk6PCEQvF2= NYLNb|VlW0GQR1XS
DoTc2-4510 MmrsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWXje|J7UUN3ME2wMlMzOjF7IN88US=> M4G3NnNCVkeHUh?=
BB65-RCC NFzWTG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXvJR|UxRTBwM{S1PVMh|ryP NGP1cJVUSU6JRWK=
HLE NGTKSHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEXZbplKSzVyPUCuN|UxPDZizszN NIDtZZdUSU6JRWK=
HCC1419 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3TxTmlEPTB;MD6zOlQxQCEQvF2= NYCw[WNpW0GQR1XS
A388 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4HBOWlEPTB;MD6zOlg2PyEQvF2= M1PEUHNCVkeHUh?=
NUGC-3 M2LXbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnXmTWM2OD1yLkO4N|c{KM7:TR?= M2DDeHNCVkeHUh?=
KYSE-180 NVPvNlFRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGfY[m1KSzVyPUCuN|kxQDlizszN NYfieoZ3W0GQR1XS
TE-6 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{WyUWlEPTB;MD60NFI1PiEQvF2= NEDFcopUSU6JRWK=
A498 M2Wyfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUHZXVM{UUN3ME2wMlQxPjd2IN88US=> NUi5b212W0GQR1XS
NCI-H1648 M4myd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYC4cG1qUUN3ME2wMlQ1OTh{IN88US=> NWXrdHlsW0GQR1XS
DU-145 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWrJR|UxRTBwNES4N|Mh|ryP MYXTRW5ITVJ?
CW-2 NGS5fJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVHVXXZoUUN3ME2wMlQ3QTF2IN88US=> NXm1fpR3W0GQR1XS
A431 Mm\CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHv2WJFKSzVyPUCuOFgzOzNizszN M1XMSnNCVkeHUh?=
SAS NVfzN|FDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlO0TWM2OD1yLkS4N|k5KM7:TR?= NHT0bYZUSU6JRWK=
NCI-H2126 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYXqeVZFUUN3ME2wMlUyQTJ4IN88US=> MoTKV2FPT0WU
NCI-H358 M1nsXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWHJR|UxRTBwNUOyNUDPxE1? NVq3TJFHW0GQR1XS
FADU NVLtdndqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVzJR|UxRTBwNUS0NFQh|ryP M4HZU3NCVkeHUh?=
ACN NI\pPXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFq0T2ZKSzVyPUCuOVUxQTRizszN M2THU3NCVkeHUh?=
HCC70 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVvmSZc3UUN3ME2wMlU4PjZzIN88US=> NH\TfHJUSU6JRWK=
NCI-H1838 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fMcWlEPTB;MD62NFI6QSEQvF2= NVHpcZV1W0GQR1XS
CAL-54 NV;reWZDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV[3S41uUUN3ME2wMlYyPjJzIN88US=> NETlbIJUSU6JRWK=
NCI-H1975 MmnRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\JR|UxRTBwNkG3Nlgh|ryP M2fGW3NCVkeHUh?=
COR-L88 NE[1cIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFzTeoZKSzVyPUCuOlQyOTNizszN M{DPNnNCVkeHUh?=
CTV-1 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWjaXHc2UUN3ME2wMlY1Ozl{IN88US=> NET1Wo5USU6JRWK=
EW-18 NI\Pb|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV;CT2VqUUN3ME2wMlY5Pjl6IN88US=> MUjTRW5ITVJ?
HCC1806 M3zQW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1rrfmlEPTB;MD62PVY3PiEQvF2= NWiyOndDW0GQR1XS
HuP-T4 NXvDdZVJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NITtUoZKSzVyPUCuOlk4PiEQvF2= M4HUTXNCVkeHUh?=
MDA-MB-361 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mk\ITWM2OD1yLkeyOlYzKM7:TR?= NUfOSlVvW0GQR1XS
NCI-H1573 NVLpTWVsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIjsWVlKSzVyPUCuO|M3OyEQvF2= NHTzUotUSU6JRWK=
KU-19-19 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHLObI1KSzVyPUCuO|c1PjRizszN NUjG[oZ5W0GQR1XS
COLO-678 NFq0S|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mk\CTWM2OD1yLkiwPFM1KM7:TR?= NXjp[WFnW0GQR1XS
C-33-A NUC0T2liT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUDJR|UxRTBwOEGyPVch|ryP M4nZV3NCVkeHUh?=
Calu-3 NEXocmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3r2O2lEPTB;MD64NVQ{PCEQvF2= NX7rcmg6W0GQR1XS
AGS NX3LUWZ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYTJR|UxRTBwOEO2OFgh|ryP M4n0[nNCVkeHUh?=
SCC-25 M{\0dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYrJR|UxRTBwOESxO|Eh|ryP MUnTRW5ITVJ?
JVM-2 NUPMV491T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYntfGtNUUN3ME2wMlg5Ojl7IN88US=> NWrVT5ZbW0GQR1XS
HCE-T M3;wUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGHlSGNKSzVyPUCuPFg1OjhizszN M3TQUHNCVkeHUh?=
ES4 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYrJR|UxRTBwOUe4N|Yh|ryP M1PKUnNCVkeHUh?=
EKVX MoXsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3qwO2lEPTB;MT6wNVA3PCEQvF2= Mm\SV2FPT0WU
D-542MG NUXK[YQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{Poe2lEPTB;MT6wNVA3PCEQvF2= NIDxRoJUSU6JRWK=
SW1116 NE\2VFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkH1TWM2OD1zLkCxNlg4KM7:TR?= MYHTRW5ITVJ?
5637 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWnJR|UxRTFwMEG1NUDPxE1? NGLNb3FUSU6JRWK=
HT-1376 NH;Y[|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlnGTWM2OD1zLkCxOVE{KM7:TR?= NYXKVZp2W0GQR1XS
NB69 M4nTWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MojyTWM2OD1zLkCyPVQ2KM7:TR?= NYKwc5V5W0GQR1XS
YKG-1 M2fQeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWrMd3R6UUN3ME2xMlA2PDF7IN88US=> MkHqV2FPT0WU
EW-3 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX;JR|UxRTFwMEe4PFMh|ryP MV3TRW5ITVJ?
GCIY NYXyN|VRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlXNTWM2OD1zLkC4NVA1KM7:TR?= MXTTRW5ITVJ?
SK-MES-1 NVfRdlFPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1XBR2lEPTB;MT6xNVQ5PyEQvF2= MoDBV2FPT0WU
PANC-08-13 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MW\JR|UxRTFwMU[0NVYh|ryP NIjEUG1USU6JRWK=
SK-NEP-1 NE[3S4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIPNO4pKSzVyPUGuNVc2OTNizszN MXPTRW5ITVJ?
SW954 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYnke3UzUUN3ME2xMlIxOjF2IN88US=> NFm3XJVUSU6JRWK=
NCI-SNU-5 NFvHcY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVH2WGc4UUN3ME2xMlI{QSEQvF2= M2i2VHNCVkeHUh?=
SW48 MnnxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUXlVlFCUUN3ME2xMlI2PDN{IN88US=> M16yOnNCVkeHUh?=
HT-3 MkTvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGrkZoJKSzVyPUGuNlg4PTNizszN NFnvcYRUSU6JRWK=
ETK-1 M3;uTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3MTWM2OD1zLkO3OFU3KM7:TR?= MUHTRW5ITVJ?
SCC-15 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmnUTWM2OD1zLkO5OFUyKM7:TR?= MW\TRW5ITVJ?
DU-4475 NUPwboNLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVXJR|UxRTFwNECxNlEh|ryP MlvSV2FPT0WU
NB5 NEPZ[IpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVfJR|UxRTFwNEGzNVch|ryP MlvvV2FPT0WU
CFPAC-1 NWfEcnZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIPPTpBKSzVyPUGuOFI1QTNizszN Mk\tV2FPT0WU
NCI-H630 M{\tN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXm3d2dlUUN3ME2xMlQ2PTh{IN88US=> NGnuV|FUSU6JRWK=
NCI-H82 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHTDV|FKSzVyPUGuOVQxODZizszN M1n3T3NCVkeHUh?=
ECC10 NIGwfmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1nBe2lEPTB;MT61OVM3QSEQvF2= NVvDR4ZNW0GQR1XS
K5 MljCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnfUTWM2OD1zLkW4N|U4KM7:TR?= M2qwWXNCVkeHUh?=
ME-180 NWXtdFc2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFm3R4FKSzVyPUGuOlExQTZizszN Ml;5V2FPT0WU
KYSE-410 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlfLTWM2OD1zLk[1OlczKM7:TR?= M4L3[XNCVkeHUh?=
G-401 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHO5U4tKSzVyPUGuOlc1OTNizszN MWDTRW5ITVJ?
TGBC24TKB MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX\JR|UxRTFwNkiyN{DPxE1? MoPhV2FPT0WU
Detroit562 M2HYSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmX2TWM2OD1zLkewNVUzKM7:TR?= M3S1RnNCVkeHUh?=
OE19 NXHhcFM2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFXLfJNKSzVyPUGuO|E2OTJizszN M3TY[HNCVkeHUh?=
CAKI-1 NFy4XmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGfMTIpKSzVyPUGuO|gzOTFizszN MVnTRW5ITVJ?
TE-12 NWCxbXc2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHHWdpVKSzVyPUGuPFA1OTRizszN MnnKV2FPT0WU
NCI-H1666 M{\WOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1T2NWlEPTB;MT64NFk1QCEQvF2= NVPBTohDW0GQR1XS
TE-1 M2n5WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVzJR|UxRTFwOEG0O|Uh|ryP MoTQV2FPT0WU
CAL-12T M2PqVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEfpfG1KSzVyPUGuPFg6PDVizszN MXXTRW5ITVJ?
TE-8 MkLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV7JR|UxRTFwOUGzO|ch|ryP MVnTRW5ITVJ?
KYSE-270 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVXJR|UxRTJwMEK3N|Ih|ryP MUXTRW5ITVJ?
GMS-10 Ml\3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkTpTWM2OD1{LkCzOVE4KM7:TR?= NVraSGtQW0GQR1XS
A2780 NUPVVnI5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2HZWmlEPTB;Mj6wOlI6PCEQvF2= NWrFXoh2W0GQR1XS
OMC-1 MmjlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHLL[JhKSzVyPUKuNFgyPjlizszN NX72O21mW0GQR1XS
LoVo M4ThWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUW3e3hiUUN3ME2yMlExPzl5IN88US=> MlrZV2FPT0WU
PANC-03-27 Ml35S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkHOTWM2OD1{LkG2OlMyKM7:TR?= Mlv5V2FPT0WU
MDA-MB-157 M3G0Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHHC[GVKSzVyPUKuNlE5OjhizszN NFLaZYdUSU6JRWK=
CaR-1 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlPRTWM2OD1{LkK4NlgyKM7:TR?= M{D5N3NCVkeHUh?=
769-P MkTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHrzfnpKSzVyPUKuNlkxOzdizszN M2HOVnNCVkeHUh?=
NB7 M3nVNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXyyOFlsUUN3ME2yMlI6Pjd4IN88US=> NFLQW4hUSU6JRWK=
MKN7 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXjJR|UxRTJwM{WzN|Uh|ryP MX3TRW5ITVJ?
NCI-H1048 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MY\JR|UxRTJwNEmxOVgh|ryP NUHJPIRzW0GQR1XS
RCM-1 NV3PWGluT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYnqZ3lQUUN3ME2yMlUzQTN6IN88US=> NWOyd5pWW0GQR1XS
HT55 NWDWS3NLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGXJOVRKSzVyPUKuOVc{QCEQvF2= NInqNZZUSU6JRWK=
HCC1569 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXi5XmxkUUN3ME2yMlU5Ojl5IN88US=> MmS2V2FPT0WU
LXF-289 NWK1XGV3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4D0dWlEPTB;Mj62N|U3PSEQvF2= NFPtdJlUSU6JRWK=
OVCAR-3 MkH3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NU\VN5hwUUN3ME2yMlY4OTZ5IN88US=> MYTTRW5ITVJ?
TE-10 MofpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXLsOWI5UUN3ME2yMlY5ODd6IN88US=> NEmwSlRUSU6JRWK=
SNU-C2B NUXuW2FZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHzVPXdKSzVyPUKuOlg3OTZizszN NH3UWGNUSU6JRWK=
LB1047-RCC MkHwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml6xTWM2OD1{Lke0PFg5KM7:TR?= M4TkfHNCVkeHUh?=
SN12C NFrPe2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NI\VR2ZKSzVyPUKuPVE6PjRizszN M1PCNHNCVkeHUh?=
786-0 NUjnRmtMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2DDOmlEPTB;Mz6wOlQxQCEQvF2= M2HQTXNCVkeHUh?=
HT-29 NWLS[WczT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGXwUGZKSzVyPUOuNFc{ODlizszN M1;0dnNCVkeHUh?=
RPMI-7951 MorLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXuySpBNUUN3ME2zMlA4PTlizszN NXrGRpdFW0GQR1XS
NBsusSR MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV;ZPWJyUUN3ME2zMlE5OjV2IN88US=> NEjVOG5USU6JRWK=
NKM-1 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkDuTWM2OD1|LkG4O|Q1KM7:TR?= NYL5b|JVW0GQR1XS
Capan-2 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV\JR|UxRTNwNE[4O|Uh|ryP M4DoZXNCVkeHUh?=
MKN1 NVXXbFJLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXrJR|UxRTNwNEexNFgh|ryP MVHTRW5ITVJ?
OAW-42 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NU\6So9YUUN3ME2zMlUxODJ4IN88US=> MnrUV2FPT0WU
SKG-IIIa MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3yyXmlEPTB;Mz61NlI{PyEQvF2= NXziZ3dGW0GQR1XS
no-11 NGPvfoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWLJR|UxRTNwNUO1OlQh|ryP MmWyV2FPT0WU
NY MoXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV\JR|UxRTNwNUO2OVUh|ryP MoPhV2FPT0WU
HEC-1 NFfNTGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NULyd5dyUUN3ME2zMlU5QTVizszN NHHo[oFUSU6JRWK=
NCI-H441 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVHJR|UxRTNwNUm4OFEh|ryP MWrTRW5ITVJ?
NCI-H2009 NUDrZ|RLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIHGRopKSzVyPUOuOlEzOTZizszN NXXWXpI5W0GQR1XS
T47D MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2LITWlEPTB;Mz62NlIyPyEQvF2= NV7PSGliW0GQR1XS
SNU-449 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\qdYRKSzVyPUOuOlU5OjZizszN NY\ZdZVwW0GQR1XS
NCI-SNU-1 NW\Yclg4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVvJR|UxRTNwNkm3N|Uh|ryP MXTTRW5ITVJ?
BT-20 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYPlcVlkUUN3ME2zMlY6Pzl3IN88US=> M1XUZXNCVkeHUh?=
LS-123 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXfJR|UxRTNwN{SyPFQh|ryP MmHVV2FPT0WU
8305C MnPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEPyV3NKSzVyPUOuO|U6OTFizszN NX7sVYdRW0GQR1XS
OCUB-M MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2HKOmlEPTB;Mz63OlE5PyEQvF2= MYTTRW5ITVJ?
KOSC-2 NUm4R3V2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX3JR|UxRTNwOEO0OVEh|ryP MkfVV2FPT0WU
NCI-H1693 MnvFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFXYSGlKSzVyPUOuPFQyQDFizszN M13OXnNCVkeHUh?=
TE-9 NYXaW5VjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2HIeGlEPTB;Mz64OFM5OiEQvF2= NInacGZUSU6JRWK=
MV-4-11 NIKx[lVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkTvTWM2OD1|Lki3PVk1KM7:TR?= M17Nd3NCVkeHUh?=
GAMG NWPmN|NHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlfqTWM2OD1|LkmxN|E1KM7:TR?= MUjTRW5ITVJ?
KNS-62 MmS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIn0fldKSzVyPUOuPVQ4OzFizszN Mkn2V2FPT0WU
MC116 NFzQfmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3LXUGlEPTB;Mz65OVQ5QSEQvF2= MWXTRW5ITVJ?
647-V MnPES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUDJR|UxRTNwOUi0OVIh|ryP MWPTRW5ITVJ?
U-87-MG NIXONlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NU\yXm5LUUN3ME20MlExPDhzIN88US=> MkfQV2FPT0WU
RPMI-8226 NX73S3NMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEi2WWJKSzVyPUSuNVE3OzFizszN NFixd3FUSU6JRWK=
SW1417 NVrTW5NbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3vFV2lEPTB;ND6xNlE1PyEQvF2= NHfHZpBUSU6JRWK=
LAMA-84 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlHLTWM2OD12LkG3NFIh|ryP MmTOV2FPT0WU
LS-513 MoHtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVraOoZ6UUN3ME20MlMyOjF5IN88US=> MWnTRW5ITVJ?
KLE M4DjeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIXpSoFKSzVyPUSuOFA5OTlizszN MnjiV2FPT0WU
HCT-116 MnXQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVfJR|UxRTRwNEGwNFch|ryP NX3Fe2I6W0GQR1XS
EPLC-272H Mk\YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mnf2TWM2OD12LkSxOVM{KM7:TR?= M37OVHNCVkeHUh?=
KS-1 M2\YOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkHrTWM2OD12LkWwPFg6KM7:TR?= MYjTRW5ITVJ?
HT-1197 Mon5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2O3SmlEPTB;ND61NlY3QSEQvF2= MkC5V2FPT0WU
LCLC-97TM1 MmDWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIHlXI5KSzVyPUSuOVM3QDZizszN NVXROnJKW0GQR1XS
ES5 MmL3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3Hsd2lEPTB;ND64N|czOyEQvF2= MUDTRW5ITVJ?
CTB-1 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlTyTWM2OD12Lki0PFgh|ryP NUDEeIxRW0GQR1XS
HL-60 NH;VTYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2X2dGlEPTB;ND64OlYyOSEQvF2= Mn;UV2FPT0WU
VM-CUB-1 NVzNSG9iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmD2TWM2OD12Lki2PFE6KM7:TR?= NVzTSm1UW0GQR1XS
MEG-01 NG\HZo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGTMepdKSzVyPUSuPVk1ODNizszN MVrTRW5ITVJ?
KYSE-520 M{\YT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX7JR|UxRTVwMkC4N|kh|ryP M1z6cHNCVkeHUh?=
HuO-3N1 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIXGdodKSzVyPUWuNlQxPDNizszN M3zRR3NCVkeHUh?=
SW620 NV;lNWpMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NELRN2NKSzVyPUWuNlQ6PjRizszN MnHtV2FPT0WU
U031 MnnUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1PzUWlEPTB;NT6yOVQzPCEQvF2= MVTTRW5ITVJ?
TE-5 M2CweWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{XqcGlEPTB;NT60NFg2KM7:TR?= MYfTRW5ITVJ?
NCI-H747 NUewWVJXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTVwNEK0O|Ih|ryP MX3TRW5ITVJ?
MG-63 NHPpN3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVPDTnpEUUN3ME21MlQ5PzZ{IN88US=> NYDBW4sxW0GQR1XS
HC-1 MnHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYPJR|UxRTVwNUG4N|kh|ryP Mnq3V2FPT0WU
HCC2998 M2HxV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVf5dXRyUUN3ME21MlUzPjF3IN88US=> NFXKXXdUSU6JRWK=
NTERA-S-cl-D1 M17kN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWHsUYh6UUN3ME21MlU1PTN5IN88US=> M3Gw[3NCVkeHUh?=
KINGS-1 NEm0XFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn;2TWM2OD13Lk[wPVQ1KM7:TR?= MkjGV2FPT0WU
D-423MG MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFS1[2NKSzVyPUWuOlE4ODVizszN NXH1bWZMW0GQR1XS
SW962 NUmyWppxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYHVe2hIUUN3ME21MlYzODN{IN88US=> MmXlV2FPT0WU
LOXIMVI NHThT|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGm4SldKSzVyPUWuOlM5PzNizszN M2rrWXNCVkeHUh?=
LS-411N MlGzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUHTZ|VYUUN3ME21Mlc6PDRzIN88US=> MVnTRW5ITVJ?
NCI-H2291 NX3wNHlNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkP5TWM2OD13Lkm4PVQ{KM7:TR?= NIi2[FRUSU6JRWK=
A549 NH;TeW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF7CWHlKSzVyPU[uNVI2PTNizszN MX7TRW5ITVJ?
LS-1034 MkixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NELMemNKSzVyPU[uNlA4ODZizszN NXLlSmNuW0GQR1XS
NB14 NHnFS4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3rmeGlEPTB;Nj60N|g{PiEQvF2= MoLkV2FPT0WU
NCI-H1299 M{m5e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXO0R5NEUUN3ME22MlY{OTdzIN88US=> NHznRo1USU6JRWK=
BT-549 M3HZZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEXF[3dKSzVyPU[uOlY5QDlizszN NXfZN2dJW0GQR1XS
J-RT3-T3-5 NWG5[5V6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3H2eWlEPTB;Nj64Olkh|ryP MnL0V2FPT0WU
SW756 M4Pmb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGjMUWlKSzVyPU[uPVEyPzZizszN NI\NN4tUSU6JRWK=
DJM-1 NE[0RW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWDFRZUxUUN3ME22MlkzODF{IN88US=> M4L3N3NCVkeHUh?=
GP5d NFPCc4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUH3SoFqUUN3ME22Mlk4Ozl2IN88US=> M1;sfXNCVkeHUh?=
MOLT-4 NITGfVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHT4PW9KSzVyPUeuNFIyOzVizszN NU\SZVdNW0GQR1XS
NCI-H28 M335UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXPTb5F[UUN3ME23MlE3PDB3IN88US=> M3jqOnNCVkeHUh?=
MN-60 NHrZVmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3y3XGlEPTB;Nz6yPFA5QSEQvF2= NHPOS3ZUSU6JRWK=
RMG-I MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1jNOWlEPTB;Nz6zPVI6PiEQvF2= MkniV2FPT0WU
COLO-800 NI\XOGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFy3TVdKSzVyPUeuOFE1PDZizszN M2n6dnNCVkeHUh?=
DB NIi4R3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWTJR|UxRTdwNkGwNFUh|ryP NV;IbVhwW0GQR1XS
Ca-Ski NWP4ZnA5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NG\IXIhKSzVyPUeuOlQzPTlizszN NVrY[4xZW0GQR1XS
HEL MmnHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{XubmlEPTB;Nz63NVIxOyEQvF2= MXXTRW5ITVJ?
NH-12 NWDE[IpLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1SyfGlEPTB;Nz63NlgxQCEQvF2= MmTPV2FPT0WU
LB373-MEL-D MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1vhbWlEPTB;Nz63Olc4OSEQvF2= NGflV4JUSU6JRWK=
SW900 NUHjOFRiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYXJR|UxRTdwOEKxNlEh|ryP NGr2NVZUSU6JRWK=
JVM-3 NIPEWIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIn6d2FKSzVyPUeuPFk2QTlizszN MoizV2FPT0WU
OAW-28 NUDIUIY1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2TtV2lEPTB;Nz65OFU4QCEQvF2= M3;TSXNCVkeHUh?=
KURAMOCHI MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIfTSoZKSzVyPUeuPVQ5OTFizszN MWLTRW5ITVJ?
BE-13 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVPJR|UxRTdwOUixNVIh|ryP NGS2SFlUSU6JRWK=
VMRC-RCZ MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYXtXGJOUUN3ME24MlAyPjl5IN88US=> NFjjVVVUSU6JRWK=
NCI-H727 MoHaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUfDc2lUUUN3ME24MlExPDJizszN MkW5V2FPT0WU
SW1710 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmXPTWM2OD16LkG4OVE2KM7:TR?= NFrsXXJUSU6JRWK=
D-502MG NXHnbXE1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFLXfmZKSzVyPUiuNlkzQDJizszN M2HQU3NCVkeHUh?=
NCI-H1993 Mk[zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYnJR|UxRThwM{O2N|Eh|ryP NIGze3lUSU6JRWK=
SCC-4 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYL3PGhUUUN3ME24MlQ1ODV7IN88US=> M3iwbXNCVkeHUh?=
HAL-01 NV;nWHZST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2fiTGlEPTB;OD61NVkyKM7:TR?= NWfWcFhJW0GQR1XS
GT3TKB M1i5OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M37ETmlEPTB;OD62O|k3PCEQvF2= MV7TRW5ITVJ?
SK-OV-3 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHHWO4pKSzVyPUiuO|E{OjlizszN NEfMU3RUSU6JRWK=
COLO-829 M37NWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHTx[WlKSzVyPUiuPFA6PzZizszN MX\TRW5ITVJ?
OCI-AML2 NX3M[HpkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4j4eGlEPTB;OD65OVQ5OSEQvF2= MYPTRW5ITVJ?
OS-RC-2 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4Wz[mlEPTB;OT6wNlE6KM7:TR?= NV;sPYRSW0GQR1XS
BFTC-909 NVnRbGw{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHewXJpKSzVyPUmuNFY4QTlizszN MYnTRW5ITVJ?
EW-11 NH3SW|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFnrd5BKSzVyPUmuNVc3PTNizszN MVLTRW5ITVJ?
HCE-4 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmPaTWM2OD17LkKxOVU5KM7:TR?= MXHTRW5ITVJ?
BALL-1 M4TW[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkDWTWM2OD17LkKxPVA4KM7:TR?= M4fZ[3NCVkeHUh?=
SF539 Mmn5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIjmUnhKSzVyPUmuNlM2PjJizszN MYHTRW5ITVJ?
CAMA-1 NXPzVGhKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoDKTWM2OD17LkK4NVI5KM7:TR?= M122bnNCVkeHUh?=
C32 MmHrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlLsTWM2OD17LkOzNFY1KM7:TR?= MUPTRW5ITVJ?
NCI-H1703 NYiyXWJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2O4Z2lEPTB;OT6zOFM4PSEQvF2= Ml\uV2FPT0WU
NCI-H1650 M{[5TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFPERndKSzVyPUmuOlA6PDZizszN MnzrV2FPT0WU
NCI-H1563 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mom3TWM2OD17Lke2NFMyKM7:TR?= NUDhXZhOW0GQR1XS
CAL-85-1 NX;ablAzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYTzVGtJUUN3ME25Mlg4Ozh|IN88US=> MYTTRW5ITVJ?
UM-UC-3 M3\0XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX\JR|UxRTlwOUWwN{DPxE1? Mki3V2FPT0WU
BxPC-3 M1\aXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV7RT2FPUUN3ME2xNE4xQTd{IN88US=> NYPUXWRLW0GQR1XS
MHH-PREB-1 M4HMNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXvhe5R3UUN3ME2xNE4yQTl7IN88US=> Mn;PV2FPT0WU
DEL M4jleGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NITmTZpKSzVyPUGwMlM6PDZizszN NF7ac|dUSU6JRWK=
HuCCT1 M4\SR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHKzeodKSzVyPUGwMlYxOzNizszN M3nROHNCVkeHUh?=
OVCAR-4 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFfZRo9KSzVyPUGwMlg5OzVizszN MVjTRW5ITVJ?
CAL-72 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYC1[G9yUUN3ME2xNE46OzlzIN88US=> M1uybnNCVkeHUh?=
HCC1954 NXfEUItxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXrJR|UxRTFzLkC3OVQh|ryP M2O2e3NCVkeHUh?=
EFO-21 MkTIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXK4OYh2UUN3ME2xNU4yODR3IN88US=> M{X3TnNCVkeHUh?=
FTC-133 MnnCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn;6TWM2OD1zMT6xOFA4KM7:TR?= MoDKV2FPT0WU
SK-MEL-24 M2[1UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVHJR|UxRTFzLkKzOlYh|ryP M3r4d3NCVkeHUh?=
UACC-62 NGnNXmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnHnTWM2OD1zMT6yN|Y5KM7:TR?= M3z0WXNCVkeHUh?=
NCI-H650 NF;Tbm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnLBTWM2OD1zMT6yOFE5KM7:TR?= NHW5bo5USU6JRWK=
ALL-PO M1;rWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M331UmlEPTB;MUGuNlUyOiEQvF2= MYDTRW5ITVJ?
T84 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH7vVm5KSzVyPUGxMlM6ODdizszN MoLrV2FPT0WU
IST-MEL1 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NU\oXGh7UUN3ME2xNU41PTV7IN88US=> NHu5TmFUSU6JRWK=
SW626 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoDRTWM2OD1zMT61O|U2KM7:TR?= MlvHV2FPT0WU
RPMI-2650 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYXK[VVPUUN3ME2xNU42QDh3IN88US=> NHroO5VUSU6JRWK=
MC-IXC NXO1VIxyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYTIcVlHUUN3ME2xNU43PzJ6IN88US=> NX;COWJSW0GQR1XS
HOP-62 NWLJSpVvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlSyTWM2OD1zMT62O|Y1KM7:TR?= NVr3VHZzW0GQR1XS
NOS-1 NGiyVpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTFzLkexNFkh|ryP NWXKOWRZW0GQR1XS
SW1573 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTFzLkeyPVUh|ryP M1fjWnNCVkeHUh?=
WM-115 M2LNdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{nWOGlEPTB;MUGuO|U5QCEQvF2= MXTTRW5ITVJ?
HuO9 NFPk[Y5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4XhPGlEPTB;MUGuPFc4PCEQvF2= MmTyV2FPT0WU
YAPC M1zwNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWHJR|UxRTFzLkmyOVkh|ryP MWfTRW5ITVJ?
MDA-MB-453 NEOzOmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGWyc2xKSzVyPUGxMlk2OTVizszN MYXTRW5ITVJ?
NCI-H596 Mn:yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIjxN2RKSzVyPUGyMlA{PjlizszN M{ezdHNCVkeHUh?=
A172 NUPvVZBoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX[yb3c1UUN3ME2xNk4xPzl6IN88US=> NUXVXm5JW0GQR1XS
RS4-11 MoXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{Pa[mlEPTB;MUKuNVczPSEQvF2= NVmwOId1W0GQR1XS
HCC1937 NX;5NZBxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH65fWlKSzVyPUGyMlc2PjRizszN NYLiXG5pW0GQR1XS
SW837 MnTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYLpVno4UUN3ME2xNk46ODJ6IN88US=> Mk\PV2FPT0WU
NMC-G1 MnroS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmrvTWM2OD1zMj65NlM1KM7:TR?= MUDTRW5ITVJ?
PFSK-1 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MojZTWM2OD1zMz6wOkDPxE1? NHPJbmtUSU6JRWK=
DBTRG-05MG MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF;WZY9KSzVyPUGzMlA3OzJizszN MorqV2FPT0WU
SK-UT-1 Mm[5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHPqTmFKSzVyPUGzMlExQDNizszN NGn3OYtUSU6JRWK=
OVCAR-5 NIjWeYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXTO[2pXUUN3ME2xN{4yPTl|IN88US=> MVzTRW5ITVJ?
8505C NXfVcXljT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3j6e2lEPTB;MUOuNlA3PyEQvF2= NGTjfoFUSU6JRWK=
SK-MEL-1 NGDNOIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXfiZ|M1UUN3ME2xN{44OTN3IN88US=> MkHEV2FPT0WU
LK-2 M1r1S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUHJR|UxRTF|Lke2N|kh|ryP NI\oPVFUSU6JRWK=
OE33 M1;sVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYLxTFh6UUN3ME2xN{44QDZizszN NF60b2dUSU6JRWK=
Ramos-2G6-4C10 M3;qOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXy5eWtwUUN3ME2xOE4xOjB{IN88US=> NGq3dXVUSU6JRWK=
EW-13 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGXXU|RKSzVyPUG0MlA{PTJizszN Mk\6V2FPT0WU
NCI-H1793 NFzrfGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHvNZ2lKSzVyPUG0MlIxQDdizszN NYDSZ2NHW0GQR1XS
BHT-101 NV;4O4ZVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3LXeGlEPTB;MUSuNlQyKM7:TR?= MV;TRW5ITVJ?
RKO MnnQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHr4VoNKSzVyPUG0MlUxPzVizszN NYjWdWJLW0GQR1XS
NEC8 M2fkWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mo\XTWM2OD1zND61OFczKM7:TR?= NGfwbYJUSU6JRWK=
PANC-10-05 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGnrcHFKSzVyPUG0MlYzPDdizszN NFuz[ItUSU6JRWK=
NCI-H2030 NEDoZotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYLJR|UxRTF2Lk[0OFgh|ryP NXvqRY1sW0GQR1XS
C2BBe1 NEfqZVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1XheGlEPTB;MUSuO|Y1KM7:TR?= MkjRV2FPT0WU
EM-2 MoiyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlO2TWM2OD1zND64OVc3KM7:TR?= NGTGXHJUSU6JRWK=
HCC1395 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3rYbmlEPTB;MUSuPVM{QCEQvF2= M2jLSXNCVkeHUh?=
A2058 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkDPTWM2OD1zNT6wOFA6KM7:TR?= MUHTRW5ITVJ?
SW1463 Mlj4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHnucHRKSzVyPUG1MlA1QDVizszN MmK3V2FPT0WU
J82 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoT1TWM2OD1zNT6wOVch|ryP NXLtdJg6W0GQR1XS
CAL-120 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUPmUXFzUUN3ME2xOU4yPDR5IN88US=> NWfReHFZW0GQR1XS
COLO-824 NFuwSItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXuxbXJzUUN3ME2xOU4yPTd7IN88US=> MWrTRW5ITVJ?
LNCaP-Clone-FGC NGrRSXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV3KVW17UUN3ME2xOU41OjR6IN88US=> M{HTN3NCVkeHUh?=
CP66-MEL MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUTIR3N7UUN3ME2xOU41Pjh6IN88US=> M2\XT3NCVkeHUh?=
OC-314 NVjVbWFWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX;JR|UxRTF3LkS3NVQh|ryP NHLJd3JUSU6JRWK=
OVCAR-8 NFjvVHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFjscmFKSzVyPUG1Mlg5PjFizszN MkjFV2FPT0WU
MFE-280 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH;kZVlKSzVyPUG2MlA1QDhizszN MXzTRW5ITVJ?
MHH-NB-11 M3j0OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWDa[VE2UUN3ME2xOk4xQDN7IN88US=> M4LicXNCVkeHUh?=
SW1990 MlHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH3MXYRKSzVyPUG2MlE4PTVizszN Mme4V2FPT0WU
U-266 NIXteFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHTGb5NKSzVyPUG2MlIzQTlizszN MmTPV2FPT0WU
MFM-223 NEf6bI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NU[4OZF3UUN3ME2xOk4{QTZ3IN88US=> NUjBTW5XW0GQR1XS
L-363 MnjNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXTTWM2OD1zNj60OVc4KM7:TR?= NWfoemNJW0GQR1XS
MCF7 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX;zfWVNUUN3ME2xOk41PzJ|IN88US=> MkTMV2FPT0WU
SK-MEL-3 NIX4VFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2nQR2lEPTB;MU[uOFc5PyEQvF2= NELpdZZUSU6JRWK=
HH NFfmfZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGPK[JRKSzVyPUG2MlUyPjJizszN NIqy[lRUSU6JRWK=
no-10 NWKyVotST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXrJR|UxRTF4Lk[zOFMh|ryP MXnTRW5ITVJ?
HuP-T3 NWPYc4lIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkXnTWM2OD1zNj62OVc3KM7:TR?= MonjV2FPT0WU
QIMR-WIL MmX6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3vrN2lEPTB;MU[uO|ExPSEQvF2= MYjTRW5ITVJ?
NCI-H1092 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoexTWM2OD1zNj64N|E3KM7:TR?= MlL5V2FPT0WU
MZ2-MEL M17kSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIj5TI1KSzVyPUG2Mlg1ODNizszN NF;iXHJUSU6JRWK=
ES3 NXjwXFNvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3fKVGlEPTB;MU[uPVE{PCEQvF2= M{fXUHNCVkeHUh?=
COLO-684 NYDxeJRmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTF4Lkm0O|ch|ryP MXfTRW5ITVJ?
NCI-H661 NEnX[VlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV7uPW86UUN3ME2xOk46Pjl2IN88US=> MnS1V2FPT0WU
CP50-MEL-B MlzpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTF5LkCzOFMh|ryP NYXa[2J[W0GQR1XS
NCI-H2405 MmPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUHjeIlpUUN3ME2xO{4yQTd2IN88US=> NITsdm9USU6JRWK=
U-2-OS NXXTdlJQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV3JR|UxRTF5LkWzNFch|ryP NVrDb5pUW0GQR1XS
RERF-LC-MS MlHpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF3Mc3FKSzVyPUG3MlU2ODhizszN NWTXXY9OW0GQR1XS
NCI-H2342 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1rSUGlEPTB;MUeuOVU4KM7:TR?= MlTZV2FPT0WU
ES8 MlewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUnJR|UxRTF5Lk[wPFch|ryP MXfTRW5ITVJ?
MOLT-16 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4TWbmlEPTB;MUeuPFk{PCEQvF2= MkTyV2FPT0WU
RH-18 M{T4OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXzJR|UxRTF6LkCwN|Uh|ryP MlfjV2FPT0WU
D-283MED MkPHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUHFTI45UUN3ME2xPE4xODh6IN88US=> MYnTRW5ITVJ?
RCC10RGB MlTKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M13xbWlEPTB;MUiuNFU2QSEQvF2= MUTTRW5ITVJ?
NCI-H1437 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3rRfWlEPTB;MUiuNVY1OSEQvF2= MlX0V2FPT0WU
SW982 M1HE[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXPpWG5KUUN3ME2xPE4zPjdzIN88US=> NYfESJZDW0GQR1XS
IST-MES1 NVzTSHV5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3qzcmlEPTB;MUiuOFQzQCEQvF2= M3XiVHNCVkeHUh?=
A704 NFvDR5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2TWO2lEPTB;MUiuOFc2OyEQvF2= MV;TRW5ITVJ?
ESS-1 NH:5OJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml35TWM2OD1zOD61NlA2KM7:TR?= NID6c2VUSU6JRWK=
SCH M4PzW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3LhdWlEPTB;MUiuOlQ2PiEQvF2= Mnu1V2FPT0WU
COLO-320-HSR NHjOOHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlGzTWM2OD1zOD63OFYh|ryP NV;GRWRpW0GQR1XS
Mo-T M2fDXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUTJR|UxRTF6LkiyNFQh|ryP M2XNcnNCVkeHUh?=
Saos-2 M4rDPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVfJR|UxRTF7LkGxOlIh|ryP NHjFSZpUSU6JRWK=
SW684 NWLtNIJET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4\yfGlEPTB;MUmuNVMzPiEQvF2= MmfGV2FPT0WU
KMOE-2 Mli3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV3JR|UxRTF7LkKyOFIh|ryP M2nLWXNCVkeHUh?=
MMAC-SF MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkHRTWM2OD1zOT6yOlA4KM7:TR?= M{THfHNCVkeHUh?=
JAR NIToW4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M32y[WlEPTB;MUmuNlk6KM7:TR?= NFnCN4JUSU6JRWK=
SK-MEL-28 NVrFc2dLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoLGTWM2OD1zOT6zN|Y{KM7:TR?= MW\TRW5ITVJ?
KNS-81-FD M1TG[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWL5fohXUUN3ME2xPU42PDZ6IN88US=> NVHYUXRDW0GQR1XS
ES7 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NITjWlRKSzVyPUG5MlYzQTJizszN NXPvdWtsW0GQR1XS
AsPC-1 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkPwTWM2OD1zOT62OFcyKM7:TR?= NEPJNnRUSU6JRWK=
NCI-H1155 MkOzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnLzTWM2OD1zOT63NlM5KM7:TR?= NHHSfYhUSU6JRWK=
KYSE-510 NXTMNodLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{\MUWlEPTB;MUmuPFc1QCEQvF2= M{[xbHNCVkeHUh?=
ES1 M4frcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVfJR|UxRTF7LkmyNVMh|ryP NU\BW2pUW0GQR1XS
PC-3 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3;Z[2lEPTB;MUmuPVYxPCEQvF2= NEG2WZBUSU6JRWK=
GCT M{fSOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYnJR|UxRTJyLkOwNlYh|ryP NE\Me5RUSU6JRWK=
KARPAS-299 NHXCNmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3G2dmlEPTB;MkCuN|QzOiEQvF2= MWnTRW5ITVJ?
DOHH-2 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUTBO3BCUUN3ME2yNE42PDZ|IN88US=> NVyxXWlHW0GQR1XS
COLO-741 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXLjc3BtUUN3ME2yNE43PiEQvF2= NXiwUFhMW0GQR1XS
NCI-H1395 NIr6d|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYjzPYNWUUN3ME2yNE43Pjl5IN88US=> M3fNRXNCVkeHUh?=
HCC1187 M1r1c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXjJR|UxRTJyLk[3N|Qh|ryP MojlV2FPT0WU
Becker M2HTU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVfJR|UxRTJyLkeyNFEh|ryP NWr3U3YxW0GQR1XS
LU-134-A MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVLIXGFxUUN3ME2yNU4yODJ4IN88US=> MV\TRW5ITVJ?
MKN45 NHn4e5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX7JR|UxRTJzLkG1OVEh|ryP M4TyXXNCVkeHUh?=
LC-2-ad Mne2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFLxTWxKSzVyPUKxMlI4OjlizszN MY\TRW5ITVJ?
EW-24 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1LkcmlEPTB;MkGuN|k1PSEQvF2= M3HNb3NCVkeHUh?=
SK-N-AS M{P5Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWLZVodWUUN3ME2yNU45Ojd4IN88US=> NX\hZ49YW0GQR1XS
NCI-H2052 NFPhXXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTJzLki5OlMh|ryP NHrJRZBUSU6JRWK=
A4-Fuk MmHHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV\PcotLUUN3ME2yNk4yPDF7IN88US=> MUPTRW5ITVJ?
NB10 M2P1NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoDGTWM2OD1{Mj6yN|cyKM7:TR?= NVTxXIF6W0GQR1XS
CHP-212 NWn1SHZYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmXkTWM2OD1{Mj6zNlIzKM7:TR?= M{XGWHNCVkeHUh?=
KM12 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXz3[phXUUN3ME2yNk4{PTZizszN Mk\DV2FPT0WU
JEG-3 M2f4ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4HwbGlEPTB;MkKuN|c5KM7:TR?= NXvLZYJiW0GQR1XS
LN-405 M3nQfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3zqTWlEPTB;MkKuOVkyOyEQvF2= NUnV[5RtW0GQR1XS
HCT-15 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1LmOWlEPTB;MkKuO|Q1OSEQvF2= NUTrN2plW0GQR1XS
MLMA NFPycWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXr5RWdMUUN3ME2yNk44PDdizszN M2fpb3NCVkeHUh?=
GI-1 NIPXdo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH7oUoxKSzVyPUKyMlc3PThizszN Mn3oV2FPT0WU
RT-112 M{LjOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGHlZYVKSzVyPUKyMlg3OTZizszN MlLKV2FPT0WU
MPP-89 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1Xmc2lEPTB;MkKuPFY3OSEQvF2= Mmj0V2FPT0WU
A3-KAW MlLHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVrJR|UxRTJ|LkGwNFMh|ryP NHixZoNUSU6JRWK=
KALS-1 MkHTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnDS2lbUUN3ME2yN{4yPDF2IN88US=> M3;rZ3NCVkeHUh?=
SF126 NH\aT2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFe1bmNKSzVyPUKzMlY6OjRizszN NXnKeFVyW0GQR1XS
SiHa NIPY[4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\pN4dKSzVyPUKzMlk{OjdizszN NEDEPJNUSU6JRWK=
MDA-MB-415 M1LnfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3HtSWlEPTB;MkOuPVQ6QSEQvF2= NGPyempUSU6JRWK=
Daoy MkWzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\JR|UxRTJ2LkGyOkDPxE1? M3;5PHNCVkeHUh?=
COR-L23 M3\xcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoLDTWM2OD1{ND6xO|Y4KM7:TR?= M4nTe3NCVkeHUh?=
KG-1 M2PXOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2\CN2lEPTB;MkSuNVkzQCEQvF2= NWf4eW1KW0GQR1XS
L-428 M1\5PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn3MTWM2OD1{ND61O|kyKM7:TR?= M1\ObnNCVkeHUh?=
NCI-H520 M3TJPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4X5cmlEPTB;MkSuPFg3OSEQvF2= M2\DRnNCVkeHUh?=
COLO-792 NX7MNnZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1jqPGlEPTB;MkWuNlc{OiEQvF2= NWrkVXY{W0GQR1XS
NB12 M1S2T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4m1fGlEPTB;MkWuNlk1PyEQvF2= M1Lnc3NCVkeHUh?=
GAK NIHEfYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGHrfXZKSzVyPUK1MlI6PjNizszN NGTaVmNUSU6JRWK=
SW780 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2TtfGlEPTB;MkWuN|I3PCEQvF2= MV;TRW5ITVJ?
GB-1 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHrLXolKSzVyPUK1MlQxPjlizszN M162SXNCVkeHUh?=
P12-ICHIKAWA MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUf2W29lUUN3ME2yOU41Pzh3IN88US=> NWraS25LW0GQR1XS
NCI-H1651 M1zw[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIXsT|ZKSzVyPUK1MlU6PyEQvF2= MWLTRW5ITVJ?
KE-37 NFe5PItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmrpTWM2OD1{NT63N|E2KM7:TR?= MnvBV2FPT0WU
CCRF-CEM MmLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NET4dplKSzVyPUK1Mlk3PyEQvF2= NWnHZWZJW0GQR1XS
SF295 Mn7sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3\w[GlEPTB;Mk[uNFQzPSEQvF2= MnPtV2FPT0WU
G-361 NGHVO2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWjDbHlnUUN3ME2yOk4yODJ5IN88US=> M2S2bnNCVkeHUh?=
HOP-92 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX7JR|UxRTJ4LkGyNlYh|ryP NYXFd2FbW0GQR1XS
UMC-11 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2nnO2lEPTB;Mk[uOFUyPCEQvF2= NXfzbYNNW0GQR1XS
IST-SL1 M3fyU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{L3ZWlEPTB;Mk[uOlU6OSEQvF2= M{LQeHNCVkeHUh?=
TE-11 NYHnS2pVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGLzNnNKSzVyPUK2Mlc4PTJizszN MV3TRW5ITVJ?
NCI-H1304 NVT3S|hTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2m4OGlEPTB;Mk[uPVExQCEQvF2= NGq5[JdUSU6JRWK=
SJSA-1 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWXJR|UxRTJ5LkCxO|Yh|ryP MXzTRW5ITVJ?
BCPAP MmHwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLZVFJiUUN3ME2yO{4yOzdizszN Mk\6V2FPT0WU
HTC-C3 NWXRbYxrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIPB[|FKSzVyPUK3MlI2PjFizszN M1\LWHNCVkeHUh?=
EW-16 NU[wRnlLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnyxTWM2OD1{Nz6yPVQ4KM7:TR?= MVzTRW5ITVJ?
HT-144 M3y2WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYO4XY1yUUN3ME2yO{41ODN{IN88US=> NX;Ze45MW0GQR1XS
MHH-ES-1 Mn7yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4DxdWlEPTB;MkeuOFQ1PyEQvF2= M{PKOXNCVkeHUh?=
T98G M3LDPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M33mUGlEPTB;MkeuOVg1PiEQvF2= MnzJV2FPT0WU
RPMI-8866 NYDjVY9iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHKwbWVKSzVyPUK3Mlc2PjJizszN NHu5S5dUSU6JRWK=
BEN MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{HKeWlEPTB;MkeuPFUyPyEQvF2= MVnTRW5ITVJ?
MDA-MB-231 NELYUZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHXtOHlKSzVyPUK4MlI4QTVizszN M2T3WnNCVkeHUh?=
HuH-7 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHL0Z5lKSzVyPUK4MlQxOjhizszN NH65XIVUSU6JRWK=
SK-N-FI NYXVNVQ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmfZTWM2OD1{OD60N|Mh|ryP NVq4b5B7W0GQR1XS
AN3-CA NEW0cJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVnJR|UxRTJ6LkSzPVUh|ryP M2nZSHNCVkeHUh?=
EGI-1 Mn7wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIjsW|dKSzVyPUK4MlU6OjhizszN MmXuV2FPT0WU
697 M1q2XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1jZbGlEPTB;MkiuOlM{OSEQvF2= NU\5Z3VKW0GQR1XS
TCCSUP MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVPJPGF6UUN3ME2yPE43PDF6IN88US=> NVXVUFFiW0GQR1XS
GR-ST MmPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIr2NFNKSzVyPUK4MlY3QTZizszN MYDTRW5ITVJ?
SK-N-DZ NVK1bm9iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXu5S4sxUUN3ME2yPE43QDh3IN88US=> NXnsbmoyW0GQR1XS
MIA-PaCa-2 NETuPYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2nxPWlEPTB;MkiuO|k2QSEQvF2= MVPTRW5ITVJ?
IGR-1 MkXVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4[3e2lEPTB;MkiuPFg4PCEQvF2= NGjGWm9USU6JRWK=
BFTC-905 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1uzbGlEPTB;MkmuNlcxPSEQvF2= NVS4ZmlQW0GQR1XS
NCI-H1581 Mlz6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn\VTWM2OD1{OT6zNVQ2KM7:TR?= MXPTRW5ITVJ?
RD M1f3fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYO0[WdOUUN3ME2yPU42OjN|IN88US=> NUPMRoJnW0GQR1XS
SF268 MlH3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVXJR|UxRTJ7LkW5N|Eh|ryP NHHMd2hUSU6JRWK=
SHP-77 M2nNdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEjKZ21KSzVyPUK5MlYyQDJizszN MVTTRW5ITVJ?
D-566MG MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGPlcWRKSzVyPUK5Mlk{QTNizszN NU\0V2t3W0GQR1XS
TGBC1TKB NFzLOFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEji[VNKSzVyPUOwMlEzOzhizszN MnvYV2FPT0WU
MEL-HO NIH6W4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1fhOmlEPTB;M{CuNVQzOyEQvF2= NYe5dlB4W0GQR1XS
SJRH30 MnmyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHviVmpKSzVyPUOwMlIyODhizszN M1n5RnNCVkeHUh?=
D-336MG MlTnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1rGWWlEPTB;M{CuNlg6OiEQvF2= MojZV2FPT0WU
C3A MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NILuNGNKSzVyPUOwMlI6OjdizszN MUHTRW5ITVJ?
Calu-6 M{DMTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fGPGlEPTB;M{CuNlk3OyEQvF2= MVvTRW5ITVJ?
MZ1-PC NGWwVVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{DkN2lEPTB;M{CuN|k{KM7:TR?= M4jJOHNCVkeHUh?=
KYSE-70 MnXKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWHFZWl7UUN3ME2zNE42OTF2IN88US=> NUTtXY02W0GQR1XS
CAPAN-1 NUPYfGs2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUXJR|UxRTNyLkWxPFEh|ryP M{fUZnNCVkeHUh?=
DK-MG NUPqe2VpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml7WTWM2OD1|MD61OFU3KM7:TR?= NV3kWXl5W0GQR1XS
SK-HEP-1 M4fKW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MorTTWM2OD1|MD62N|I3KM7:TR?= M3rmPXNCVkeHUh?=
MS-1 M4GwOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NELscm5KSzVyPUOwMlg5QDlizszN NVK4OnRvW0GQR1XS
GI-ME-N NWLmcI9MT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEjIWYVKSzVyPUOxMlA2PzFizszN NFnaTYdUSU6JRWK=
NCI-H510A NH7B[3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{W1eGlEPTB;M{GuOFAxPiEQvF2= M17aTnNCVkeHUh?=
NB17 NFvVUINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEXOcYlKSzVyPUOxMlUyQDVizszN MWPTRW5ITVJ?
639-V M3PkUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkjDTWM2OD1|MT61NlQ{KM7:TR?= MYPTRW5ITVJ?
CAL-51 NWnwNHZ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVLJR|UxRTNzLkW2Olch|ryP MUTTRW5ITVJ?
HGC-27 NFPt[WJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVLJR|UxRTNzLkW4O|Mh|ryP MX\TRW5ITVJ?
GOTO NWOxWpdQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MW\JR|UxRTNzLki1NFYh|ryP MlfIV2FPT0WU
ChaGo-K-1 NWDpU4NtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3WxT2lEPTB;M{KuNFA4KM7:TR?= NX\tcpE6W0GQR1XS
RO82-W-1 M{nx[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWjJR|UxRTN{LkG2NFQh|ryP M1G2O3NCVkeHUh?=
SH-4 NUjOUZFJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUfJR|UxRTN{LkG4OVgh|ryP MkfaV2FPT0WU
A204 M2riRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmTxTWM2OD1|Mj61NFY6KM7:TR?= NF\ifI1USU6JRWK=
DMS-273 NHnGOWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MonETWM2OD1|Mj61N|IzKM7:TR?= MlXQV2FPT0WU
KGN NHnIfWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4DDd2lEPTB;M{KuOlM{KM7:TR?= M2jON3NCVkeHUh?=
SK-MEL-2 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVPJR|UxRTN{Lk[1Nlch|ryP M{mw[HNCVkeHUh?=
NCI-H2228 MoLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MW\JR|UxRTN{Lk[2NFIh|ryP MoHJV2FPT0WU
MKN28 MlyyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVTQZWh6UUN3ME2zNk44QDN6IN88US=> M{f6VHNCVkeHUh?=
H-EMC-SS MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVXJR|UxRTN{Lkm2O|gh|ryP MUHTRW5ITVJ?
ATN-1 M2fpOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIX3blZKSzVyPUOzMlE1OTZizszN MYHTRW5ITVJ?
D-263MG MnPvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWPJR|UxRTN|LkizO|gh|ryP NXLifJl6W0GQR1XS
LU-135 NUntR3VpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn71TWM2OD1|Mz64PFI6KM7:TR?= MVTTRW5ITVJ?
C8166 NWPjUWxCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M33Dc2lEPTB;M{OuPFg2PCEQvF2= MYHTRW5ITVJ?
T-24 NVPOd|htT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHnK[3FKSzVyPUO0MlAzODVizszN MYjTRW5ITVJ?
Mewo MlPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkT2TWM2OD1|ND6xN|Q6KM7:TR?= M{nDbHNCVkeHUh?=
22RV1 MnHDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV\JR|UxRTN2LkG3OVQh|ryP NInhVo5USU6JRWK=
KM-H2 NHjIS21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2fURmlEPTB;M{SuNVc4QSEQvF2= NGLqWJlUSU6JRWK=
NCI-H2122 MnKxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVfBSW9CUUN3ME2zOE4{PDdzIN88US=> MV3TRW5ITVJ?
ABC-1 NX[4[XpGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHfKOZlKSzVyPUO0MlM3QTNizszN MljRV2FPT0WU
NCI-H1355 Mn72S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mk\NTWM2OD1|ND6zPFg6KM7:TR?= M1PS[HNCVkeHUh?=
NOMO-1 NWPnTXd5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2XESWlEPTB;M{SuOVcxOyEQvF2= M{iySnNCVkeHUh?=
MZ7-mel NI[4b|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4DZUGlEPTB;M{SuOlQ5PyEQvF2= MUTTRW5ITVJ?
NCI-H810 M37I[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHm5OoRKSzVyPUO0MlczPzhizszN MWfTRW5ITVJ?
D-392MG MmW4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWnJR|UxRTN3LkC1OlUh|ryP M365enNCVkeHUh?=
LB771-HNC NYrxVINKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoeyTWM2OD1|NT6xOlU5KM7:TR?= M13XWHNCVkeHUh?=
COLO-679 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MknzTWM2OD1|NT6zPFgh|ryP MlziV2FPT0WU
SK-PN-DW NFTCeXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIHHVWdKSzVyPUO1MlQ{PjlizszN M2rEfXNCVkeHUh?=
VA-ES-BJ MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn62TWM2OD1|NT60OlQ6KM7:TR?= M3L2O3NCVkeHUh?=
KNS-42 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkntTWM2OD1|NT61PFI3KM7:TR?= NWrUOI5RW0GQR1XS
RVH-421 NUn6[GVVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4LrfWlEPTB;M{WuO|Y1PSEQvF2= MkHkV2FPT0WU
P30-OHK MlXES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX\JR|UxRTN3Lki3OVIh|ryP NIfOfWlUSU6JRWK=
G-402 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M33HdmlEPTB;M{WuPVg3PyEQvF2= NFPDTmhUSU6JRWK=
S-117 NE\RR3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4nLc2lEPTB;M{[uN|AxQCEQvF2= MmLiV2FPT0WU
RXF393 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUHvbpJxUUN3ME2zOk4{Pzh3IN88US=> M33CbHNCVkeHUh?=
LCLC-103H NFuzVIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTN4Lke4NFMh|ryP NVztW3pWW0GQR1XS
U-118-MG MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnvOTWM2OD1|Nj64PFQ4KM7:TR?= Ml\jV2FPT0WU
8-MG-BA MmLrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mor1TWM2OD1|Nj65OFg{KM7:TR?= M{SzUXNCVkeHUh?=
MFH-ino NIPRVGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MY\JR|UxRTN5LkOzO|Eh|ryP NFrPeI1USU6JRWK=
NCI-H23 NY\tbHpET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{DUcWlEPTB;M{euOFE6PiEQvF2= Mmf5V2FPT0WU
NCI-H446 M4W0UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NW\JVFhiUUN3ME2zO{41QDZ{IN88US=> NHjYVZBUSU6JRWK=
LU-99A M{DwTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVrENJVHUUN3ME2zO{42PzNzIN88US=> NYfpdIRWW0GQR1XS
KP-N-YN M2jhemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4K1eWlEPTB;M{euOlE6PSEQvF2= NFjTeIZUSU6JRWK=
SCC-9 NH\kNW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVr1b|hNUUN3ME2zO{44QDN6IN88US=> NGXMN4NUSU6JRWK=
EFM-19 NHf5fpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NY[zdWpFUUN3ME2zO{44QTZ5IN88US=> M1HIWHNCVkeHUh?=
A427 NXXtRZVMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn6xTWM2OD1|Nz65NVA4KM7:TR?= M3PsdHNCVkeHUh?=
LB831-BLC MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYLJR|UxRTN6Lk[wN|kh|ryP Mk\NV2FPT0WU
HOS NUTKR4lzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlTYTWM2OD1|OT62Nlc{KM7:TR?= NXjtdWp{W0GQR1XS
LAN-6 M{\0SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWTJR|UxRTRyLkCxNVIh|ryP M37X[nNCVkeHUh?=
U251 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXnvdVRiUUN3ME20NE41ODV2IN88US=> MX;TRW5ITVJ?
SNU-387 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUnBfXVrUUN3ME20NE41PTV|IN88US=> NXzDZmJLW0GQR1XS
DMS-79 M1fzOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUjJR|UxRTRyLkW4PFkh|ryP MUDTRW5ITVJ?
SK-LU-1 M3;4bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVfiXlJwUUN3ME20NE43PTZ6IN88US=> MoPGV2FPT0WU
HT M{j1fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWnuU3RpUUN3ME20NE43PjN7IN88US=> MlLGV2FPT0WU
KP-N-YS NEexXIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NETFPWdKSzVyPUSwMlY4PjhizszN Mn;XV2FPT0WU
DMS-114 NUHTPIxIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEDId3hKSzVyPUSwMlg{PzRizszN NXHKXZo1W0GQR1XS
HUTU-80 MmrZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUja[nJMUUN3ME20NU4xPTZ7IN88US=> NHG3d|RUSU6JRWK=
ONS-76 Mk\lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVrkb|FJUUN3ME20NU41PzB7IN88US=> NEn2OpVUSU6JRWK=
A673 NHnnbFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NETMbXVKSzVyPUSxMlUyPTdizszN M{OwZnNCVkeHUh?=
HPAF-II MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUWwNGFvUUN3ME20NU43PzB7IN88US=> MkX6V2FPT0WU
UACC-257 MnLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH;Kc29KSzVyPUSxMlc{PjlizszN NWfx[GFzW0GQR1XS
EW-22 NVLEcIc5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mlr5TWM2OD12MT64Olk4KM7:TR?= MUDTRW5ITVJ?
NCI-H1755 NVrGSm1DT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnPQTWM2OD12MT64O|I2KM7:TR?= NIPESIZUSU6JRWK=
KYSE-150 M1jHUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3nuOGlEPTB;NEKuNVc5OiEQvF2= NGjL[JVUSU6JRWK=
CGTH-W-1 NVv2fnFLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3\UN2lEPTB;NEKuOFk2PSEQvF2= M1raT3NCVkeHUh?=
NB13 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml;STWM2OD12Mj62NlE4KM7:TR?= NYLGPIx2W0GQR1XS
SW872 NY[zbodCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmO4TWM2OD12Mj62N|MyKM7:TR?= NYrKNW5vW0GQR1XS
KP-4 M2TSN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M362UWlEPTB;NEKuPFg{OiEQvF2= NXfvbYxSW0GQR1XS
HCC38 M3PFOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVvJR|UxRTR{Lkm2NVgh|ryP MUPTRW5ITVJ?
BB49-HNC M2ftPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYHJR|UxRTR|LkKzOVYh|ryP NI\sVWRUSU6JRWK=
CAL-62 Mm\lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4\6VmlEPTB;NEOuOFAzQCEQvF2= MkXaV2FPT0WU
NCI-H2029 MkK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYi1TngyUUN3ME20N{42PThzIN88US=> MXXTRW5ITVJ?
M14 MkewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVTJR|UxRTR2LkGzN|Ih|ryP Mnf6V2FPT0WU
COLO-680N M{\Lemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2HPcGlEPTB;NESuN|M6KM7:TR?= NHexSIlUSU6JRWK=
Hs-578-T M2nyZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYnHToRDUUN3ME20OU4xOjl2IN88US=> MWHTRW5ITVJ?
MSTO-211H NVG0TZd2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlvWTWM2OD12NT65OFgzKM7:TR?= MYPTRW5ITVJ?
EW-1 M4Lt[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV2zWFJRUUN3ME20OU46Pjh7IN88US=> NF3yZXhUSU6JRWK=
SW948 MkL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MonQTWM2OD12Nj60OFYzKM7:TR?= MoeyV2FPT0WU
NCI-H460 NX3MUXRET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYnJR|UxRTR4LkWyN{DPxE1? NVrY[FIyW0GQR1XS
CAS-1 NFPON49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MojVTWM2OD12Nj63O|AyKM7:TR?= M2TjNHNCVkeHUh?=
TGBC11TKB NF\JcmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3fHPGlEPTB;NEeuNVc4PyEQvF2= NHv4R2xUSU6JRWK=
HD-MY-Z Ml;wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{ntUWlEPTB;NEiuO|g3KM7:TR?= NWOySFI2W0GQR1XS
NCI-H226 NUexSFhDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3y2TGlEPTB;NEmuO|c5PSEQvF2= NIHGU|FUSU6JRWK=
PA-1 MmrZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYfJR|UxRTR7LkizN|Uh|ryP MXrTRW5ITVJ?
LB2518-MEL NVnUW3ZDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXvFRnlKUUN3ME20PU45PzJ|IN88US=> MmTmV2FPT0WU
A101D Ml;5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1\5bmlEPTB;NEmuPVQzPSEQvF2= NEfVbGVUSU6JRWK=
NCI-H2087 M13RUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF73codKSzVyPUS5Mlk3QDJizszN NFTXVYFUSU6JRWK=

... Click to View More Cell Line Experimental Data

In vivo Daily oral administration of BIBW2992 at 20 mg/kg for 25 days results in dramatic tumor regression with a cumulative treated/control tumor volume ratio (T/C ratio) of 2%. Reduced phosphorylation of EGFR and AKT is confirmed by immunohistochemical staining of tissue sections. Therefore, like lapatinib and neratinib, BIBW2992 is a next generation tyrosine kinase inhibitor (TKI) that inhibits human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases irreversibly. BIBW2992 is not only active against EGFR mutations targeted by first generation TKIs like Erlotinib or Gefitinib, but also against those insensitive to these standard therapies. [1]

Protocol

Kinase Assay:

[1]

+ Expand

In vitro kinase activity assays:

The wild type tyrosine kinase domain of the human EGFR as well as that of the EGFR L858R/T790M double mutant are fused to Glutathione-S-transferase (GST), and extracted. Enzyme activity is then assayed in the presence of the inhibitor BIBW2992, serially diluted in 50% DMSO. A random polymer pEY (4:1) is used as substrate and biotinylated pEY (bio-pEY) is added as a tracer substrate. The kinase domain of HER2 is cloned using the baculovirus system and extracted similarly to that of EGFR kinase. Details of assays for EGFR, HER2, SRC, BIRK and VEGFR2 kinase activity are available in Supplementary information.
Cell Research:

[1]

+ Expand
  • Cell lines: NSCLC cells
  • Concentrations: 0-10 μM
  • Incubation Time: 1 hour
  • Method:

    1 × 104 NSCLC cells are transferred into each well of a 96-well plate and cultured overnight in serum-free media for the EGFR phosphorylation assay. After addition of BIBW2992 on the next day, the plates are incubated at 37 °C for 1 hour. EGF-stimulation is done using 100 ng/mL for 10 min at room temperature. Cells are washed with ice cold PBS, extracted with 120 μL HEPEX buffer per well and shaken at room temperature for 1 hour. In all 2 × 104 cells per well is used for the HER2 phosphorylation assay. Streptavidin precoated plates are coated with anti-EGFR-biotin at 1:100 dilution in blocking buffer and c-erb2/HER2 oncoprotein Ab-5(Clone N24)-Biotin. Cell extracts is then transferred to the antibody-coated wells and incubated at room temperature for 1 hour. Extinction is measured at 450 nm.


    (Only for Reference)
Animal Research:

[1]

+ Expand
  • Animal Models: Athymic NMRI-nu/nu female mice
  • Formulation: In 0.5% methocellulose-0.4% polysorbate-80 (Tween 80)
  • Dosages: 20 mg/kg
  • Administration: Oral administration
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 97 mg/mL (199.61 mM)
Ethanol 15 mg/mL (30.86 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
2% DMSO+30% PEG 300+5% Tween 80+ddH2O
For best results, use promptly after mixing.
10mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 485.94
Formula

C24H25ClFN5O3

CAS No. 439081-18-2
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02795156 Recruiting Non-small Cell Lung Carcinoma|Urothelial Carcinoma|Gastrointestinal Carcinoma, Non-colon|Upper Aerodigestive Tract Carcinoma SCRI Development Innovations, LLC|Foundation Medicine|Boehringer Ingelheim|Bayer September 28, 2016 Phase 2
NCT03054038 Not yet recruiting Non-Small Cell Lung Carcinoma Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) February 2017 Phase 1
NCT02979977 Not yet recruiting Squamous Cell Cancers of the Head and Neck Aarti Bhatia|National Comprehensive Cancer Network|Boehringer Ingelheim|Yale University December 2016 Phase 2
NCT02876081 Not yet recruiting SMALL CELL LUNG CARCINOMA Groupe Hospitalier Paris Saint Joseph December 2016 Phase 2
NCT02183883 Recruiting Non-small Cell Lung Cancer University College, London|Boehringer Ingelheim December 2016 Phase 2
NCT02423525 Recruiting Brain Cancer Santosh Kesari|Boehringer Ingelheim|John Wayne Cancer Institute October 2016 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    What’s the recommendation about reconstitution of the compound for in vivo animal study?

  • Answer:

    For in vivo experiment of afatinib, we recommend 0.5% methylcellulose/0.2% Tween 80 as vehicle.

EGFR Signaling Pathway Map

EGFR Inhibitors with Unique Features

Related EGFR Products

Tags: buy Afatinib (BIBW2992) | Afatinib (BIBW2992) supplier | purchase Afatinib (BIBW2992) | Afatinib (BIBW2992) cost | Afatinib (BIBW2992) manufacturer | order Afatinib (BIBW2992) | Afatinib (BIBW2992) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID